Associated Papers
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors.
Nakamura Y et al.
Nature Medicine, 2025
39284955 (PubMed )
Supplement: 41591_2024_3244_MOESM2_ESM.xlsx › Suppementary_Table_1
Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities.
Zhang H et al.
Elife, 2024
39432560 (PubMed )
Supplement: elife-95453-supp1.xlsx › S1c
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Hayes TK et al.
Nature Communications, 2024
38548752 (PubMed )
Supplement: 41467_2024_45594_MOESM4_ESM.xlsx › All
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Bayle A et al.
Molecular Cancer, 2023
37924050 (PubMed )
Supplement: 12943_2023_1878_MOESM2_ESM.xlsx › Feuil1
Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer.
Lu HY et al.
Oncology Letters, 2012
The effect of gefitinib on B-RAF mutant non-small cell lung cancer and transfectants.
Toyooka S et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2007
Select a paper to view details